The Role of the Immune System in Anti-Tumour Responses

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Drugs & Aging

• Publication date

  1995-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2165/00002512-199507040-00002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunity to Oncogenic Proteins

  1995cited by this paper
• Inhibition of bispecific monoclonal antibody (bsAb)‐targeted cytolysis by human anti‐mouse antibodies in ovarian carcinoma patients treated with bsAb‐targeted activated T‐lymphocytes

  1995cited by this paper
• Clinical and immunological effects of treatment with murine anti-CD3 monoclonal antibody along with interleukin 2 in patients with cancer.

  1995cited by this paper
• Role of B7-1 in mediating an immune response to myeloid leukemia cells.

  1995cited by this paper
• Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer.

  1994cited by this paper
• The B7 and CD28 receptor families.

  1994cited by this paper
• Phase I study of intravenously applied bispecific antibody in renal cell cancer patients receiving subcutaneous interleukin 2.

  1994cited by this paper
• p53, a potential target for tumor-directed T cells.

  1994cited by this paper
• An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation.

  1994cited by this paper
• Source of unique tumour antigens

  1994cited by this paper
• The molecular basis of leukemia.

  1994cited by this paper
• Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity

  1994cited by this paper
• A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS–family transcription factor, ERG

  1994cited by this paper
• Bispecific anti-CD22/anti-CD3-ricin A chain immunotoxin is cytotoxic to Daudi lymphoma cells but not T cells in vitro and shows both A-chain-mediated and LAK-T-mediated killing.

  1994cited by this paper
• Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma

  1994cited by this paper
• Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.

  1994cited by this paper
• Melanocyte lineage-specific antigen gp100 is recognized by melanoma- derived tumor-infiltrating lymphocytes

  1994cited by this paper
• T cell epitopes encompassing the mutational hot spot position 61 of p21 ras. Promiscuity in ras peptide binding to HLA

  1994cited by this paper
• Generation of the AML1‐EVI‐1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia.

  1994cited by this paper
• Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.

  1994cited by this paper
• T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells

  1994cited by this paper
• Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.

  1994cited by this paper
• Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein.

  1994cited by this paper
• MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation.

  1994cited by this paper
• Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity.

  1994cited by this paper
• Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

  1994cited by this paper
• Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation.

  1994cited by this paper
• Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.

  1994cited by this paper
• A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

  1994cited by this paper
• Lysis of ras oncogene-transformed cells by specific cytotoxic T lymphocytes elicited by primary in vitro immunization with mutated ras peptide

  1994cited by this paper
• Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

  1994cited by this paper
• In vitro generation of human cytolytic T-cells specific for peptides derived from the HER-2/neu protooncogene protein.

  1994cited by this paper
• Use of bispecific antibodies in the therapy of tumors.

  1993cited by this paper
• Two distinct portions of LTG19/ENL at 19p13 are involved in t(11;19) leukemia.

  1993cited by this paper
• The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

  1993cited by this paper
• Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surface.

  1993cited by this paper
• EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts

  1993cited by this paper
• Immunogenicity of fusion proteins

  1993cited by this paper
• Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation.

  1993cited by this paper
• Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma.

  1993cited by this paper
• Molecular basis of the t(8;21) translocation in acute myeloid leukaemia.

  1993cited by this paper
• Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells.

  1993cited by this paper
• Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma

  1993cited by this paper
• Cytotoxic T-cell response and in vivo protection against tumor cells harboring activated ras proto-oncogenes.

  1993cited by this paper
• The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1.

  1993cited by this paper
• Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma

  1993cited by this paper
• Identifying strategies for immune intervention.

  1993cited by this paper
• TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.

  1993cited by this paper
• Identification of two cytotoxic T lymphocyte-recognized epitopes in the Ras protein

  1993cited by this paper
• Vaccinations with tumor cells genetically engineered to produce different cytokines: effectivity not superior to a classical adjuvant.

  1993cited by this paper
• Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia.

  1993cited by this paper
• The role of the CD28 receptor during T cell responses to antigen.

  1993cited by this paper
• Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

  1993cited by this paper
• Fusion between a novel Krüppel‐like zinc finger gene and the retinoic acid receptor‐alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia.

  1993cited by this paper
• Acute promyelocytic leukaemia and the t(15;17) translocation.

  1993cited by this paper
• Overlapping epitopes encompassing a point mutation (12 Gly → Arg) in p21 ras can be recognized by HLA‐DR, ‐DP and ‐DQ restricted T cells

  1993cited by this paper
• T cell clones specific for p21 ras‐derived peptides: Characterization of their fine specificity and HLA restriction

  1993cited by this paper
• Human CD4 lymphocytes specifically recognize a peptide representing the fusion region of the hybrid protein pml/RAR alpha present in acute promyelocytic leukemia cells.

  1993cited by this paper
• Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia.

  1992cited by this paper
• Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours

  1992cited by this paper
• The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene.

  1992cited by this paper
• The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot.

  1992cited by this paper
• Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias.

  1992cited by this paper
• Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene.

  1992cited by this paper
• Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer.

  1992cited by this paper
• Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4.

  1992cited by this paper
• A trithorax–like gene is interrupted by chromosome 11q23 translocations in acute leukaemias

  1992cited by this paper
• T-cell immunity to the joining region of p210BCR-ABL protein.

  1992cited by this paper
• Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens.

  1992cited by this paper
• Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC.

  1992cited by this paper
• Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas.

  1992cited by this paper
• Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation.

  1992cited by this paper
• Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy.

  1992cited by this paper
• The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA

  1992cited by this paper
• TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.

  1992cited by this paper
• Initial Trial of Bispecific Antibody-Mediated Immunotherapy of CD15-Bearing Tumors: Cytotoxicity of Human Tumor Cells Using a Bispecific Antibody Comprised of Anti-CD15 (MoAb PM81) and Anti-CD64/FcγRI (MoAb 32)

  1992cited by this paper
• Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia.

  1992cited by this paper
• T cell recognition of transforming proteins encoded by mutated ras proto-oncogenes.

  1991cited by this paper
• Humoral immune responses to tumor-associated carbohydrate antigens.

  1991cited by this paper
• Specific release of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-alpha, and IFN-gamma by human tumor-infiltrating lymphocytes after autologous tumor stimulation.

  1991cited by this paper
• Conversion of a self peptide sequence into a Kd-restricted neo-antigen by a Tyr substitution

  1991cited by this paper
• Identification of unique murine tumor associated antigens by tumor infiltrating lymphocytes using tumor specific secretion of interferon-gamma and tumor necrosis factor.

  1991cited by this paper
• Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras proteins

  1991cited by this paper
• Thyroid dysfunction associated with immunotherapy for patients with cancer

  1991cited by this paper
• Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes

  1991cited by this paper
• A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

  1991cited by this paper
• Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients.

  1991cited by this paper
• Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation

  1990cited by this paper
• Myocarditis or acute myocardial infarction associated with interleukin‐2 therapy for cancer

  1990cited by this paper
• The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product

  1990cited by this paper
• A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL.

  1990cited by this paper
• Problems, controversies, and perspectives on the clinical use of interleukin-2.

  1990cited by this paper
• Correlation between clinical response to interleukin 2 therapy and sustained production of tumor necrosis factor.

  1990cited by this paper
• Role of the CD28 receptor in T-cell activation.

  1990cited by this paper
• Preliminary trial of specific targeting therapy against malignant glioma.

  1990cited by this paper
• Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor.

  1990cited by this paper
• Unique murine tumor-associated antigens identified by tumor infiltrating lymphocytes.

  1990cited by this paper
• Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity.

  1990cited by this paper
• Augmentation of antibody dependent cell mediated cytotoxicity following in vivo therapy with recombinant interleukin 2.

  1990cited by this paper
• Cardiorespiratory effects of immunotherapy with interleukin-2.

  1989cited by this paper

• Review article: stem cell transplantation for the treatment of gastrointestinal diseases – current applications and future perspectives

  2007cites this paper
• Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma

  2003cites this paper
• Identification of the Neoplastically Transformed Cells in Marek's Disease Herpesvirus-Induced Lymphomas: Recognition by the Monoclonal Antibody AV37

  2002cites this paper
• 10 Graft-versus-leukaemia

  1997cites this paper